Biogen (BIIB) Current Assets (2009 - 2026)
Biogen (BIIB) posted Current Assets of $7.58 billion for Q3 2026, down 15.1% from $8.94 billion a year earlier but up 3.8% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen's Current Assets came in at $8.97 billion, up 20.3% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- In prior years, Biogen's Current Assets was $7.46 billion in FY2024 (+8.7%), $6.86 billion in FY2023 (-29.9%), $9.79 billion in FY2022 (+24.6%) and $7.86 billion in FY2021 (+14.1%).
- Quarterly Current Assets has run from a low of $6.76 billion in Q1 2024 to a high of $10.43 billion in Q2 2023 over five years.
- On a year-over-year basis, Current Assets increased in six of the last eight quarters, with growth averaging 10.2%.
- The strongest year-over-year quarter for Current Assets in the past five years was Q3 2022, with growth of 36.4%; the weakest was Q2 2024, with a decline of 31.9%.
- According to Business Quant data, Current Assets for the three prior quarters was $7.31 billion (Q2 2026), $9.19 billion (Q1 2026) and $8.97 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 7.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.58 Bn |
| Jun 30, 2026 | 7.31 Bn |
| Mar 31, 2026 | 9.19 Bn |
| Dec 31, 2025 | 8.97 Bn |
| Sep 30, 2025 | 8.94 Bn |
| Jun 30, 2025 | 7.97 Bn |
| Mar 31, 2025 | 7.63 Bn |
| Dec 31, 2024 | 7.46 Bn |
| Sep 30, 2024 | 6.83 Bn |
| Jun 30, 2024 | 7.11 Bn |
| Mar 31, 2024 | 6.76 Bn |
| Dec 31, 2023 | 6.86 Bn |
| Sep 30, 2023 | 8.45 Bn |
| Jun 30, 2023 | 10.43 Bn |
| Mar 31, 2023 | 9.76 Bn |
| Dec 31, 2022 | 9.79 Bn |
| Sep 30, 2022 | 9.77 Bn |
| Jun 30, 2022 | 9.74 Bn |
| Mar 31, 2022 | 7.92 Bn |
| Dec 31, 2021 | 7.86 Bn |
API Access
Biogen Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();